AzTrials
AzTrials

X-ray Contrast Media Adverse ReactionNCT03533348

Preparative Fasting Before Contrast-enhanced Computed Tomography

An observational study of X-ray Contrast Media Adverse Reaction, run by HaEmek Medical Center, Israel at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to determine whether there is a need for preparative fasting prior to contrast-enhanced computed tomography (CT). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
X-ray Contrast Media Adverse Reaction
How many people
2,148 participants
Where
1 siteIsrael
Study dates
31 Jul 2018to 10 Oct 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The participants are inpatients who are undergoing contrast enhanced computed tomography that will be divided into two cohorts. The first will need at least 4 hours of fasting prior to contrast enhanced computed tomography scans and the second will be allowed to eat and drink freely prior to contrast enhanced computed tomography scans

Who may be able to join

  • Patients undergoing contrast-enhanced CT scans

Who cannot join

  • Pateints undergoing CT scans while sedated.
  • Patients under the age of 18 years
  • Patients who suffer from a mental disorder that prevents them:
  • from understanding what s/he consents to and/ or
  • from choosing decisively and/ or
  • from communicating his/her consent
  • Patients who were instructed not to eat due to requirements of a specific study (for example.. computed tomography enterography-CTE)

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Emek Medical Center

    Afula, 18341

Other trials in Israel

About this study

Official title: Preparative Fasting for Contrast-enhanced Computed tomography-a Prospective Randomized Study

The study aims to determine whether there is a need for preparative fasting prior to contrast-enhanced computed tomography (CT).

Read the detailed description

The use of fasting orders for imaging and other procedures is common, this seemingly benign practice can lead to real harms to patients and poor satisfaction with their care. The nothing per os (NPO) order is sometimes used in CT scans because gastrointestinal tract contents can interrupt visualization of the intestinal lumen, but more commonly NPO orders are are thought to protect all supine patients from aspiration during delivery of intravenous contrast. There is limited evidence to support such practice of NPO orders prior to contrast-enhanced CT scans. The authors' main objective is to determine if there is a need for preparative fasting prior to contrast-enhanced CT scans.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03533348
Study groupRoleWhat they receive
Fasting armPatients will need at least 4 hours of fasting prior to contrast-enhanced CT scans.
No fastingPatients are allowed to eat and drink freely prior to contrast-enhanced CT scans.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Aspiration pneumonitis

    Rates of aspiration pneumonitis after contrast-enhanced CT scans

    Measured: Day 1

Secondary outcomes (1)
  1. Gastrointestinal symptoms

    Rates of nausea and vomiting after contrast-enhanced CT scans

    Measured: Hour 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2018
  2. Study start31 Jul 2018
  3. Primary completion10 Oct 2019
  4. Study completion10 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
2,148 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03533348
Sponsor's protocol ID
0167-17-EMC
Status last verified
Oct 2019
First submitted
30 Apr 2018
Last updated
22 Oct 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Neeman Z, Abu Ata M, Touma E, Saliba W, Barnett-Griness O, Gralnek IM, Rock W, Bisharat N. Is fasting still necessary prior to contrast-enhanced computed tomography? A randomized clinical study. Eur Radiol. 2021 Mar;31(3):1451-1459. doi: 10.1007/s00330-020-07255-0. Epub 2020 Sep 8.

    PubMed 32901302

Questions about this trial

What is this clinical trial studying?

An observational study of X-ray Contrast Media Adverse Reaction, run by HaEmek Medical Center, Israel at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Aspiration pneumonitis (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03533348, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in